Sanofi India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on April 29, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sanofi India Limited held its 70th AGM on April 29, 2026, where all 11 resolutions were passed with overwhelming shareholder approval (97.8% to 99.99% in favour). Key business included adoption of FY 2025 financial statements and declaration of total dividend of Rs.123 per equity share (Rs.75 interim already paid plus Rs.48 final dividend). The board saw leadership changes with appointment of Ms. Sudipta Chakraborty as Whole-time Director and two new Independent Directors - Ms. Rajani Kesari and Mr. Siraj Azmat Chaudhry for 5-year terms. Related party transactions with Sanofi-Aventis Singapore and Sanofi Healthcare India were also approved. Total voter turnout was 85.5% with 80,754 shareholders on record.
All resolutions passed with strong majorities, indicating shareholder confidence. The dividend declaration provides direct cash returns to investors. Board composition changes and related party approvals maintain governance compliance and ongoing affiliate relationships.